Have you been diagnosed with Coeliac Disease?
Recruitment for this study has now closed. If you are interested in further clinical trials in this indication, please register your interest online and we will be in touch when the next opportunity arises.
We are researching a new vaccine therapy to treat Coeliac Disease. Currently, the only way to manage the disease is by the lifelong and strict avoidance of gluten in the diet. A gluten-free diet is exceptionally demanding for patients, expensive and can be difficult to maintain as gluten is used extensively in modern food production. Even small amounts of gluten can cause damage.
Our study will explore whether the use of a novel vaccine therapy can switch off the immune response and restore gluten tolerance in sufferers.
We are currently recruiting study participants who:
- Are between the ages of 18 and 70.
- Have been medically diagnosed with Coeliac Disease.
To see if you are eligible complete the questionnaire or call the Clinical Trials Centre on 07 5456 3797.
Full title: A Bioequivalence Study of Nexvax2 in HLA-DQ2.5+ Adults with Coeliac Disease
Ethics Approval – Bellberry Limited
If you experience difficulty completing the survey please email email@example.com.
USC Health Clinics
9 Ochre Way
SIPPY DOWNS QLD 4556